A Biotech Bash - Recs and Wrecks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : A Biotech Bash - Recs and Wrecks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: r. peter Dale who wrote (7)	8/25/1997 5:39:00 PM
From: Czechsinthemail	of 171

peter, While you've got me on a role, I'll also mention SIBIA Neurosciences (SIBI). This is a little company working with big science. They are engaged in developing small molecule therapeutics for nervous system disorders including Parkinson's disease, Alzheimer's disease, stroke, depression, head trauma, epilepsy, chronic pain, schizophrenia and other neurological, psychiatric and neurodegenerative disorders. Their lead compound SIB-1508Y for Parkinson's disease is in Phase I clinicals. They have a number of collaborations with major pharms. They also have a pile of cash. The market cap is about $63.9 million and cash & equivalents come to $37.8 million. The ratio of market cap to cash is about 1.7--ridiculously low considering the diversity and richness of SIBI's research program. It is hard to believe you can buy it so cheap. SI site: exchange2000.com SIBI website: sibia.com Good hunting, Baird

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next